Congress Program

Monday, 25 June

 07:30 Registration 
 08:25
Congress Opening and 
Welcome Address
Jacob Schachter, Director, The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 08:30
Paradigm Shift in Modern Oncology
Jacob Schachter,
Director, The Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 09:00
Basic Immunology
Michal Besser,
Head of Laboratory, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 09:45
Unleashing the Immune System Against Cancer

 10:30
Coffee Break, Poster Viewing and Visit the Exhibition

 11:00
Cell α Gene Therapy
Michal Besser, Head of Laboratory, Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center, Israel

 11:45
Two Sides of the Mirror – Autoimmunity and Cancer Immunotherapy

 12:15
Bacterial Ghosts in Immunotherapy of Cancer
Werner Lubitz, CEO / CSO, BIRD-C GmbH & Co KG, Austria

 12:45
Lunch Break, Poster Viewing and Visit the Exhibition

 13:45
Check-Point Inhibitors – MOA and Future Directions


 14:15
Current Treatment of Advanced Melanoma

 14:45
Translational Immune Oncology - MSD Pipeline

 15:15  
Coffee Break, Poster Viewing and Visit the Exhibition

 15:30
Melanoma Case Study


 16:00
Oral Presentations from Selected Abstracts

 16:45  
End of Day One


Tuesday, 26 June


08:00  Registration 
09:00
Advanced Combinations of Immunotherapy – Current Knowledge and Future Plans


09:45 
NSCLC Case Study and Update on Immunotherapy in Lung Cancer

10:30
Coffee Break, Poster Viewing and Visit the Exhibition

10:45
Immunotherapy of RCC and Urothelial Cancers and Case Study


11:30
Immunotherapy for Patients with High MSI Tumors

12:00
Resistance Mechanism of Immunotherapy


12:30
Lunch Break, Poster Viewing and Visit the Exhibition

13:30
Oral Presentations from Selected Abstracts


14:15 
Case Studies
 
15:15
Coffee Break, Poster Viewing and Visit the Exhibition

15:30
Case Studies


 16:30
Closing Remarks
Jacob Schachter, Congress Chair